Clicky

Ocugen Inc(2H51) News

2H51 price today by TradingView
Date Title
Feb 13 Why Ocugen (OCGN) Is Advancing Today
Feb 12 Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration